Abstract:Nod-like receptor family pyrin domain-containing protein 12 (NLRP12) is one of the critical pattern recognition receptors which participates in the regulation of multiple inflammatory responses. Mutations in NLRP12 cause exceptionally rare NLRP12-associated autoinflammatory disease (NLRP12-AID). So far, very few patients with NLRP12-AID have been identified worldwide; therefore, limited data on the clinical phenotype and genetic profile are available. In this study, we reported 10 patients who presented mainly with periodic fever syndrome or arthritis. Next-generation sequencing (NGS) identified 6 heterozygous mutations of NLRP12 , including 2 novel null mutations. Of the patients, some with same mutations showed different clinical features. Compared to healthy controls, the increased levels of cytokines were revealed in the patients' plasmas, as well as in the supernatants of patients' cells stimulated with lipopolysaccharide (LPS) or tumor necrosis factor-α (TNF-α). The missense mutations did not change the protein expression; but decreased level of NLRP12 protein was shown in the two null mutations. And in vitro expression assay demonstrated a truncating protein induced by the frameshift mutation. Further functional studies revealed the deleterious effect of NLRP12 mutations on nuclear factor-kappa B (NF-κB) signaling. Both the null and missense mutations impaired their inhibition of NF-κB activation induced by p65. Collectively, this study reported a relatively large NLRP12-AID case series. Our findings expand the clinical spectrum, and reinforce the diversity of genetic mutations and clinical phenotypes. The NLRP12-associated disorder should be born in mind when autoinflammatory diseases are encountered in the clinical practice, especially for patients presenting with periodic fever but no other genetic cause identified.

Bypassing PELO-mediated ATPase activation of the NLR is a common pathogenic cause of NLR -associated autoinflammatory diseases

Bypassing PELO-mediated ATPase activation of NLR is a common pathogenic cause of -associated autoinflammatory diseases

NLRP12-associated autoinflammatory disease: A novel causal mutation and bioinformatics analyses

Clinical heterogeneity of NLRP12-associated autoinflammatory diseases

Lipopolysaccharide promotes NLRP3 inflammasome activation by inhibiting TFEB-mediated autophagy in NRK-52E cells

NLRP3: A promising therapeutic target for autoimmune diseases

Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotype

Unraveling the NLRP family: Structure, function, activation, critical influence on tumor progression, and potential as targets for cancer therapy

NOD-like receptors in autoimmune diseases

Distinct Molecular Mechanisms Underlying Potassium Efflux for NLRP3 Inflammasome Activation

Revealing the Mechanism of NLRP3 Inflammatory Pathway Activation through K+ Efflux Induced by PLO via Signal Point Mutations

An Exclusive NEMO B Mutation Leads to NF-κB-linked Recurrent Pneumonia by Disrupting the NEMO/IKK Complex

Palmitoylation promotes chaperone-mediated autophagic degradation of NLRP3 to modulate inflammation

NLRP3 inflammasome and its role in autoimmune diseases: A promising therapeutic target

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors

Chemical mitochondrial uncouplers share common inhibitory effect on NLRP3 inflammasome activation through inhibiting NFκB nuclear translocation

NLRP Inflammasomes in Health and Disease.

Role of the NLRP3 inflammasome in autoimmune diseases

Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors

NLRP12 c.1382dup promotes the development of Crohn's disease through the ERK/NLRP3/ IL-1β pathway

Anti-α-Internexin Autoantibody from Neuropsychiatric Lupus Induce Cognitive Damage Via Inhibiting Axonal Elongation and Promote Neuron Apoptosis